Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

[1]  F. Carrat,et al.  Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis , 2017, Hepatology.

[2]  I. Mackay,et al.  Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis , 2016, Scientific Reports.

[3]  Hwa Young Choi,et al.  Population‐based epidemiology of primary biliary cirrhosis in South Korea , 2016, Alimentary pharmacology & therapeutics.

[4]  E. Schiff,et al.  Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  C. Ponsioen,et al.  Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[6]  Roy Pardee,et al.  The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration , 2014, EGEMS.

[7]  R. Gambino,et al.  Gender specific medicine in liver diseases: a point of view. , 2014, World journal of gastroenterology.

[8]  C. Selmi,et al.  The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. , 2013, Journal of autoimmunity.

[9]  T. Kumagi,et al.  Natural history and management of primary biliary cirrhosis , 2012, Hepatic medicine : evidence and research.

[10]  C. Ponsioen,et al.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.

[11]  M. Zervos,et al.  Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool , 2011, Antimicrobial Agents and Chemotherapy.

[12]  H. Quan,et al.  Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population‐based study , 2009, Hepatology.

[13]  Jason Fine,et al.  Sample size for positive and negative predictive value in diagnostic research using case-control designs. , 2008, Biostatistics.

[14]  J. Lake,et al.  Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States , 2007, Hepatology.

[15]  Sarah M. Greene,et al.  Building a virtual cancer research organization. , 2005, Journal of the National Cancer Institute. Monographs.

[16]  B. McMahon,et al.  Prevalence of autoimmune liver disease in Alaska natives , 2002, American Journal of Gastroenterology.

[17]  E. Gold,et al.  Risk factors for primary biliary cirrhosis in a cohort of patients from the United States , 2001, Hepatology.

[18]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[19]  G. Minuk,et al.  Clinical hepatology: Profile of an urban, hospital‐based practic , 1996, Hepatology.

[20]  P. Angus,et al.  Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. , 1995, Gut.

[21]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[22]  K. Lazaridis,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.